Callan Family Office »

C4 Therapeutics shares owned by Callan Family Office

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $61k 32k 1.91

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding C4 Therapeutics

Point72 Asset Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
OrbiMed Advisors
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Millennium Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Geode Capital Management
Jane Street

View all funds holding C4 Therapeutics